NCT00529659View on ClinicalTrials.gov

A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)

PHASE2CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Sarcopenia

Interventions

DRUG

Comparator: MK-0773

MK-0773 50 mg tablets twice daily, 6 month treatment period

DRUG

Comparator: Placebo

Placebo tablets twice daily, 6 month treatment period

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00529659 - A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) | Biotech Hunter | Biotech Hunter